SCYNEXIS INC (SCYX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SCYX
See up to 3 months of SCYX. The 7-day demo opens the 1M and 3M ranges and puts SCYX on your watchlist.
Start 7-day demoLatest SCYX insider trades
- Gonzalez David Angulo - OfficerOpen-market purchase108,695 sh
- Gonzalez David Angulo - OfficerOpen-market purchase108,695 sh
Steven Keith Burke - Director
About SCYNEXIS INC (SCYX)
SCYNEXIS INC files with the SEC under CIK 0001178253 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
SCYX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 111,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SCYX insider transactions (Form 4)
3219 Form 4 filings on record, the earliest from Apr 9, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Steven Keith Burke - Director | Grant or award | Common Stock | 5,750 footnote F1 | $0.00 | - | |
| Steven Keith Burke - Director | Grant or award | Stock Option (Right to Buy) | 5,750 | $0.00 | - | |
| ||||||
 Sanjay Subramanian - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Brian Philippe Tinmouth | Grant or award | Common Stock | 2,875 footnote F1 | $0.00 | - | |
| Brian Philippe Tinmouth | Grant or award | Stock Option (Right to Buy) | 2,875 | $0.00 | - | |
| ||||||
| Guy Macdonald | Grant or award | Common Stock | 2,875 footnote F1 | $0.00 | - | |
| Guy Macdonald | Grant or award | Stock Option (Right to Buy) | 2,875 | $0.00 | - | |
| ||||||
| Armando Anido | Grant or award | Stock Option (Right to Buy) | 2,875 | $0.00 | - | |
| Armando Anido | Grant or award | Common Stock | 2,875 footnote F1 | $0.00 | - | |
| ||||||
| David C. Hastings | Grant or award | Common Stock | 2,875 footnote F1 | $0.00 | - | |
| David C. Hastings | Grant or award | Stock Option (Right to Buy) | 2,875 | $0.00 | - | |
| ||||||
| Ann Hanham | Grant or award | Stock Option (Right to Buy) | 2,875 | $0.00 | - | |
| Ann Hanham | Grant or award | Common Stock | 2,875 footnote F1 | $0.00 | - | |
| ||||||
| Gonzalez David Angulo - Officer | Open-market purchase | Common Stock | 108,695 | - footnote F1 | - | |
| Gonzalez David Angulo - Officer | Open-market purchase | Warrant to Purchase Common Stock | 108,695 | - footnote F1 | - | |
| ||||||
| Ivor Macleod - Officer | Grant or award | Common Stock | 129,833 footnote F1 | $0.00 | - | |
| ||||||
| Scott Sukenick - Officer | Grant or award | Common Stock | 129,833 footnote F1 | $0.00 | - | |
| ||||||
| Gonzalez David Angulo - Officer | Grant or award | Common Stock | 391,333 footnote F1 | $0.00 | - | |
| ||||||
| Gonzalez David Angulo - Officer | Grant or award | Common Stock | 32,500 | $0.76 | $25K | |
| Brian Philippe Tinmouth | Grant or award | Common Stock | 23,000 | $0.00 | - | |
| Brian Philippe Tinmouth | Grant or award | Stock Option | 23,000 | $0.00 | - | |
| Guy Macdonald | Grant or award | Common Stock | 23,000 | $0.00 | - | |
| Guy Macdonald | Grant or award | Stock Option | 23,000 | $0.00 | - | |
| David C. Hastings | Grant or award | Common Stock | 23,000 | $0.00 | - | |
| David C. Hastings | Grant or award | Stock Option | 23,000 | $0.00 | - | |
| Ann Hanham | Grant or award | Common Stock | 23,000 | $0.00 | - | |
| Ann Hanham | Grant or award | Stock Option | 23,000 | $0.00 | - | |
| Steven C. Gilman | Grant or award | Common stock | 23,000 | $0.00 | - | |
| Steven C. Gilman | Grant or award | Stock Option | 23,000 | $0.00 | - | |
| Armando Anido | Grant or award | Common Stock | 23,000 | $0.00 | - | |
| Armando Anido | Grant or award | Stock Option | 23,000 | $0.00 | - | |
| Gonzalez David Angulo - Officer | Grant or award | Common Stock | 23,000 | $0.84 | $19K | |
Item 1.01, 7.01, 9.01
Item 5.02, 7.01, 9.01
Item 5.02, 8.01
Item 5.03, 5.07, 8.01, 9.01
SCYX insider trading FAQ
What is the latest insider trade for SCYX?
SCYNEXIS INC (SCYX) had 2 insider filings in the last 90 days, with the most recent on 2026-09-22. The full record for SCYX runs to 19 Form 4 filings, the earliest from 2025-04-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SCYX stock?
No insider purchases of SCYX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling SCYX stock?
No insider sales of SCYX were filed in the last 90 days.
Where can I see SCYX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SCYX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Steven Keith Burke view on EDGAR
- - Sanjay Subramanian view on EDGAR
- - Brian Philippe Tinmouth view on EDGAR
- - Guy Macdonald view on EDGAR
- - Armando Anido view on EDGAR
- - David C. Hastings view on EDGAR
- - Ann Hanham view on EDGAR
- - Gonzalez David Angulo view on EDGAR
- - Ivor Macleod view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SCYX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SCYX with a 7-day demo
- SCYX on your watchlist
- Every SCYX Form 4 filing on record
- Up to 3 months of SCYX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
